Welcome to Primordia Biosystems – Pioneering the Future of in vitro Biocomputation

In Vitro Analysis Tools

Discover our state-of-the-art in vitro analysis tools, featuring a highly integrated design, 3D-MEA technology, wireless data transmission, and cutting-edge BioMEMS components, engineered to elevate the precision and efficiency of research and diagnostics.

HI-MEA

3D electrodes
Integrated electronics
Wireless Interface

ClearVis HT-3D

3D electrodes
High throughput
Clear substrate

Pathogen Detection

Introducing our advanced pathogen detection systems, which combine multimodal biosensing, electronic interfaces, and low-cost technology to revolutionize the early identification and tracking of harmful pathogens, making the world a safer and healthier place.

RoloSense

Direct virus detection
Optical transduction
Low-cost WiFi interface

BacteSign

Direct cellular detection
Integrated electronics
Highly scaled

Engineering Services

Experience unparalleled engineering services at Primordia Biosystems, where our expertise in biosensor development, research and process integration, and electronics and system design converge to deliver tailor-made solutions for your unique challenges.

Process Integration

Multi-scale: micro/meso/macro
Multi-technology: wafer/PCB/CNC
Specified outsourcing

Electronics Design

Bioelectronic Interfaces
Signal conditioning / Multiplex
Analysis / Computing / Database

Our Team

Introducing Our Team, a dynamic group of seasoned industry experts, accomplished researchers, and forward-thinking entrepreneurs, collaboratively pushing the boundaries of bioelectronic computation.

David
DeRoo

Chief Executive Officer
Co-Founder

Dave is a seasoned industry expert, boasting 30+ years of hands-on experience. He has held executive and strategic positions in leadership, marketing, and sales within prominent manufacturing corporations and multiple thriving west-coast startups.

MBA, MS in Electrical Engineering and BS in Engineering Physics.

Frank
Sommerhage

Chief Technology Officer
Co-Founder

Frank excels in biological engineering and computer science. As a university professor, his research focuses on cell-sensor interfaces, microfluidics, body-on-a-chip technology, and security-oriented sensor design. Additionally, he has co-founded two innovative startups.

PhD in Biology, MS/BS in Bioengineering and Biomimicry

Swaminathan
Rajaraman

Scientific Advisor
Co-Founder

Swami, a renowned university professor, specializes in micro and nanofabrication for biological applications. He co-founded Axion BioSystems Inc., a global leader in high-throughput microelectrode arrays and systems.

PhD/MS/BS in Electrical Engineering

About Us

Primordia Biosystems is a cutting-edge biocomputation company headquartered in California, specializing in the development of ground-breaking diagnostic analysis systems for in vitro and hybrid bioelectronic applications. Our team of seasoned experts, with a combined experience of over 50 years, brings together a wealth of knowledge spanning biotechnology, electrophysiology, cell-sensor interfaces, microfluidics, manufacturing, microbiology, and wireless systems.

At Primordia, we’re reimagining the future of bioelectronic systems by offering streamlined, miniaturized solutions designed to revolutionize applications in cell-sensor interfaces. Our innovative technologies ensure interrogation without disruption, while our wireless cloud-based analysis and evaluation platforms provide unparalleled convenience and ease of use. Furthermore, our flexible APIs enable seamless integration with biosignature-based actuation systems.

Join us on our mission to redefine the landscape of artificial inteligence and unlock the full potential of in vitro biocomputation.

Our Collaborators

Meet Our Collaborators, a diverse network of esteemed partners including innovative biotech companies and a prestigious university, working synergistically to advance the frontiers of biotechnology and bioelectronic computation.

Contact Us

Get in touch with us to learn more about our innovative solutions, explore potential collaborations, or simply to share your thoughts and inquiries – we look forward to connecting with you.